Refer to Male lower urinary-tract symptoms guidance.

FINASTERIDE

Important: Therapy notes

  • MHRA advice: Finasteride: reminder of the risk psychiatric side effects and of sexual side effects (which may persist after discontinuation of treatment) (April 2024) (www.gov.uk).
  • MHRA advice: Finasteride: rare reports of depression and suicidal thoughts (May 2017) (www.gov.uk).
  • MHRA advice: Finasteride: potential risk of male breast cancer (December 2014) (www.gov.uk).

Important: Formulation and dosage details

Formulation:

Tablets 5mg

Dosage:

Benign prostatic hyperplasia, 5mg daily (may require several months treatment before benefit is obtained).

Editorial Information

Document Id: F196